Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 18

1.

A Multi-Center Study of BRCA1 and BRCA2 Germline Mutations in Mexican-Mestizo Breast Cancer Families Reveals Mutations Unreported in Latin American Population.

Millan Catalan O, Campos-Parra AD, Vázquez-Romo R, Cantú de León D, Jacobo-Herrera N, Morales-González F, López-Camarillo C, Rodríguez-Dorantes M, López-Urrutia E, Pérez-Plasencia C.

Cancers (Basel). 2019 Aug 26;11(9). pii: E1246. doi: 10.3390/cancers11091246.

2.

Crosstalk Between Long Non-coding RNAs, Micro-RNAs and mRNAs: Deciphering Molecular Mechanisms of Master Regulators in Cancer.

López-Urrutia E, Bustamante Montes LP, Ladrón de Guevara Cervantes D, Pérez-Plasencia C, Campos-Parra AD.

Front Oncol. 2019 Jul 25;9:669. doi: 10.3389/fonc.2019.00669. eCollection 2019. Review.

3.

Cell migration and proliferation are regulated by miR-26a in colorectal cancer via the PTEN-AKT axis.

Coronel-Hernández J, López-Urrutia E, Contreras-Romero C, Delgado-Waldo I, Figueroa-González G, Campos-Parra AD, Salgado-García R, Martínez-Gutierrez A, Rodríguez-Morales M, Jacobo-Herrera N, Terrazas LI, Silva-Carmona A, López-Camarillo C, Pérez-Plasencia C.

Cancer Cell Int. 2019 Apr 2;19:80. doi: 10.1186/s12935-019-0802-5. eCollection 2019.

4.

BRCA mutations: is everything said?

López-Urrutia E, Salazar-Rojas V, Brito-Elías L, Coca-González M, Silva-García J, Sánchez-Marín D, Campos-Parra AD, Pérez-Plasencia C.

Breast Cancer Res Treat. 2019 Jan;173(1):49-54. doi: 10.1007/s10549-018-4986-5. Epub 2018 Oct 6. Review.

PMID:
30293211
5.

Long Non-Coding RNAs as New Master Regulators of Resistance to Systemic Treatments in Breast Cancer.

Campos-Parra AD, López-Urrutia E, Orozco Moreno LT, López-Camarillo C, Meza-Menchaca T, Figueroa González G, Bustamante Montes LP, Pérez-Plasencia C.

Int J Mol Sci. 2018 Sep 11;19(9). pii: E2711. doi: 10.3390/ijms19092711. Review.

6.

Alternative splicing regulation in tumor necrosis factor-mediated inflammation.

López-Urrutia E, Campos-Parra A, Herrera LA, Pérez-Plasencia C.

Oncol Lett. 2017 Nov;14(5):5114-5120. doi: 10.3892/ol.2017.6905. Epub 2017 Sep 6.

7.

Micro-RNAs as Potential Predictors of Response to Breast Cancer Systemic Therapy: Future Clinical Implications.

Campos-Parra AD, Mitznahuatl GC, Pedroza-Torres A, Romo RV, Reyes FIP, López-Urrutia E, Pérez-Plasencia C.

Int J Mol Sci. 2017 Jun 2;18(6). pii: E1182. doi: 10.3390/ijms18061182. Review.

8.

MiR-26a downregulates retinoblastoma in colorectal cancer.

López-Urrutia E, Coronel-Hernández J, García-Castillo V, Contreras-Romero C, Martínez-Gutierrez A, Estrada-Galicia D, Terrazas LI, López-Camarillo C, Maldonado-Martínez H, Jacobo-Herrera N, Pérez-Plasencia C.

Tumour Biol. 2017 Apr;39(4):1010428317695945. doi: 10.1177/1010428317695945.

PMID:
28443472
9.

Targeting Metabolic Remodeling in Triple Negative Breast Cancer in a Murine Model.

García-Castillo V, López-Urrutia E, Villanueva-Sánchez O, Ávila-Rodríguez MÁ, Zentella-Dehesa A, Cortés-González C, López-Camarillo C, Jacobo-Herrera NJ, Pérez-Plasencia C.

J Cancer. 2017 Jan 13;8(2):178-189. doi: 10.7150/jca.16387. eCollection 2017.

10.

Anti-inflammatory and Antitumor Activity of a Triple Therapy for a Colitis-Related Colorectal Cancer.

Figueroa-González G, García-Castillo V, Coronel-Hernández J, López-Urrutia E, León-Cabrera S, Arias-Romero LE, Terrazas LI, Rodríguez-Sosa M, Campos-Parra AD, Zúñiga-Calzada E, Lopez-Camarillo C, Morales-González F, Jacobo-Herrera NJ, Pérez-Plasencia C.

J Cancer. 2016 Jul 25;7(12):1632-1644. eCollection 2016.

11.

PAX8 is transcribed aberrantly in cervical tumors and derived cell lines due to complex gene rearrangements.

López-Urrutia E, Pedroza-Torres A, Fernández-Retana J, De Leon DC, Morales-González F, Jacobo-Herrera N, Peralta-Zaragoza O, García-Mendez J, García-Castillo V, Bautista-Isidro O, Pérez-Plasencia C.

Int J Oncol. 2016 Jul;49(1):371-80. doi: 10.3892/ijo.2016.3515. Epub 2016 May 11.

PMID:
27175788
12.

MicroRNAs are involved in cervical cancer development, progression, clinical outcome and improvement treatment response (Review).

González-Quintana V, Palma-Berré L, Campos-Parra AD, López-Urrutia E, Peralta-Zaragoza O, Vazquez-Romo R, Pérez-Plasencia C.

Oncol Rep. 2016 Jan;35(1):3-12. doi: 10.3892/or.2015.4369. Epub 2015 Oct 30. Review.

PMID:
26530778
13.

Transcript profiling distinguishes complete treatment responders with locally advanced cervical cancer.

Fernandez-Retana J, Lasa-Gonsebatt F, Lopez-Urrutia E, Coronel-Martínez J, Cantu De Leon D, Jacobo-Herrera N, Peralta-Zaragoza O, Perez-Montiel D, Reynoso-Noveron N, Vazquez-Romo R, Perez-Plasencia C.

Transl Oncol. 2015 Apr;8(2):77-84. doi: 10.1016/j.tranon.2015.01.003.

14.

Biochemical and proteomic analysis of spliceosome factors interacting with intron-1 of human papillomavirus type-16.

Martínez-Salazar M, López-Urrutia E, Arechaga-Ocampo E, Bonilla-Moreno R, Martínez-Castillo M, Díaz-Hernández J, Del Moral-Hernández O, Cedillo-Barrón L, Martines-Juarez V, De Nova-Ocampo M, Valdes J, Berumen J, Villegas-Sepúlveda N.

J Proteomics. 2014 Dec 5;111:184-97. doi: 10.1016/j.jprot.2014.07.029. Epub 2014 Aug 7.

PMID:
25108200
15.

Clinical evidence of the relationship between aspirin and breast cancer risk (review).

Jacobo-Herrera NJ, Pérez-Plasencia C, Camacho-Zavala E, González GF, Urrutia EL, García-Castillo V, Zentella-Dehesa A.

Oncol Rep. 2014 Aug;32(2):451. doi: 10.3892/or.2014.3270. Epub 2014 Jun 13. Review.

PMID:
24927467
16.

MicroRNAs in cervical cancer: evidences for a miRNA profile deregulated by HPV and its impact on radio-resistance.

Pedroza-Torres A, López-Urrutia E, García-Castillo V, Jacobo-Herrera N, Herrera LA, Peralta-Zaragoza O, López-Camarillo C, De Leon DC, Fernández-Retana J, Cerna-Cortés JF, Pérez-Plasencia C.

Molecules. 2014 May 16;19(5):6263-81. doi: 10.3390/molecules19056263. Review.

17.

A few nucleotide polymorphisms are sufficient to recruit nuclear factors differentially to the intron 1 of HPV-16 intratypic variants.

López-Urrutia E, Valdés J, Bonilla-Moreno R, Martínez-Salazar M, Martínez-Garcia M, Berumen J, Villegas-Sepúlveda N.

Virus Res. 2012 Jun;166(1-2):43-53. doi: 10.1016/j.virusres.2012.02.026. Epub 2012 Mar 8.

PMID:
22425557
18.

The HPV-16 E7 oncoprotein is expressed mainly from the unspliced E6/E7 transcript in cervical carcinoma C33-A cells.

del Moral-Hernández O, López-Urrutia E, Bonilla-Moreno R, Martínez-Salazar M, Arechaga-Ocampo E, Berumen J, Villegas-Sepúlveda N.

Arch Virol. 2010 Dec;155(12):1959-70. doi: 10.1007/s00705-010-0787-9. Epub 2010 Sep 24.

PMID:
20865289

Supplemental Content

Loading ...
Support Center